Posaconazole SP الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

posaconazole sp

schering-plough europe - posaconazole - candidiasis; mycoses; coccidioidomycosis; aspergillosis - antimycotics for systemic use - posaconazole sp is indicated for use in the treatment of the following fungal infections in adults (see section 5.1):- invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products;- fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b;- chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole;- coccidioidomycosis in patients with disease that is refractory to amphotericin b, itraconazole or fluconazole or in patients who are intolerant of these medicinal products;- oropharyngeal candidiasis: as first-line therapy in patients who have severe disease or are immunocompromised, in whom response to topical therapy is expected to be poor.refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective antifungal therapy.posaconazole sp is also indicated for prophylaxis of invasive fungal infections in the following patients:- patients receiving remission-induction chemotherapy for acute myelogenous leukemia (aml) or myelodysplastic syndromes (mds) expected to result in prolonged neutropenia and who areat high risk of developing invasive fungal infections;- hematopoietic stem cell transplant (hsct) recipients who are undergoing high-dose immunosuppressive therapy for graft versus host disease and who are at high risk of developing invasive fungal infections.

Aerius Oral Solution 0.5 mg/ml الأردن - الإنجليزية - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

aerius oral solution 0.5 mg/ml

مستودع أدوية أداتكو - adatco drug store - desloratadine 0.5 mg/ml - 0.5 mg/ml

CLARITINE Tablets 10 mg الأردن - الإنجليزية - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

claritine tablets 10 mg

شركة مستودع الأدوية الأردني - the jordan drugstore co - loratadine 10 mg - 10 mg

DIPROSALIC Ointment 0.5 mg, 30 mg/gm الأردن - الإنجليزية - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

diprosalic ointment 0.5 mg, 30 mg/gm

مستودع أدوية أداتكو - adatco drug store - betamethasone 0.5 mg, salicylic acid 30 mg/gm - 0.5 mg, 30 mg/gm

DIPROSONE 0.05% Cream 0.5 mg الأردن - الإنجليزية - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

diprosone 0.05% cream 0.5 mg

مستودع أدوية أداتكو - adatco drug store - betamethasone 0.5 mg - 0.5 mg

ELOCOM Cream 0.1% 1 mg/gm الأردن - الإنجليزية - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

elocom cream 0.1% 1 mg/gm

مستودع أدوية أداتكو - adatco drug store - mometasone furoate 1 mg/gm - 1 mg/gm

ELOCOM Cream 0.1% 1 mg/gm الأردن - الإنجليزية - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

elocom cream 0.1% 1 mg/gm

مستودع أدوية أداتكو - adatco drug store - mometasone furoate 1 mg/gm - 1 mg/gm

ELOCOM Ointment 0.1% 1 mg/gm الأردن - الإنجليزية - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

elocom ointment 0.1% 1 mg/gm

مستودع أدوية أداتكو - adatco drug store - mometasone furoate 1 mg/gm - 1 mg/gm

ELOCOM Ointment 0.1% 1 mg/gm الأردن - الإنجليزية - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

elocom ointment 0.1% 1 mg/gm

مستودع أدوية أداتكو - adatco drug store - mometasone furoate 1 mg/gm - 1 mg/gm

NASONEX Nasal Spray 50 mcg/metered dose الأردن - الإنجليزية - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

nasonex nasal spray 50 mcg/metered dose

مستودع أدوية أداتكو - adatco drug store - mometasone furoate 50 mcg/metered dose - 50 mcg/metered dose